Peter H. O'Donnell, MD, specializes in the treatment of
genitourinary malignancies, including prostate, kidney, and testicular cancers — with particular expertise in bladder cancer.
Smith is director of
the Genitourinary Malignancies Program and holds the Claire and John Bertucci Endowed Chair in Genitourinary Cancers in the MGH Cancer Center and is a professor of Medicine at Harvard Medical School
Not exact matches
To participate in the study, which concludes in July 2020, patients must be 18 years or older and have a histological - or cytological - proven diagnosis of a
malignancy in the lung, breast, head and neck,
genitourinary organs or ovaries or multiple myeloma.